Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation
- PMID: 10773035
Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation
Abstract
Degeneration of dopaminergicrgic neurons in the substantia nigra of the brain is a hallmark of Parkinson's disease and inflammation and oxidative stress are closely associated with the pathogenesis of degenerative neurological disorders. Treatment of rat mesencephalic mixed neuron-glia cultures with lipopolysaccharide (LPS)-activated microglia, resident immune cells of the brain, to release proinflammatory and neurotoxic factors tumor necrosis factor-alpha, interleukin-1beta, nitric oxide, and superoxide and subsequently caused damage to midbrain neurons, including dopaminergic neurons. The LPS-induced degeneration of the midbrain neurons was significantly reduced by cotreatment with naloxone, an opioid receptor antagonist. This study focused on understanding the mechanism of action for the protective effect of naloxone on dopaminergic neurons because of relevance to Parkinson's disease. Both naloxone and its opioid receptor inactive stereoisomer (+)-naloxone protected the dopaminergic neurons with equal potency. Naloxone inhibited LPS-induced activation of microglia and release of proinflammatory factors, and inhibition of microglia generation of superoxide free radical best correlated with the neuroprotective effect of naloxone isomers. To further delineate the site of action, naloxone was found to partially inhibit the binding of [(3)H]LPS to cell membranes, whereas it failed to prevent damage to dopaminergic neurons by peroxynitrite, a product of nitric oxide and superoxide. These results suggest that naloxone at least in part interferes with the binding of LPS to cell membranes to inhibit microglia activation and protect dopaminergic neurons as well as other neurons in the midbrain cultures from inflammatory damage.
Similar articles
-
Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.J Pharmacol Exp Ther. 2000 Oct;295(1):125-32. J Pharmacol Exp Ther. 2000. PMID: 10991969
-
Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons.J Pharmacol Exp Ther. 2002 Sep;302(3):1212-9. doi: 10.1124/jpet.102.035956. J Pharmacol Exp Ther. 2002. PMID: 12183682
-
Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage.J Pharmacol Exp Ther. 2001 Sep;298(3):1133-41. J Pharmacol Exp Ther. 2001. PMID: 11504811
-
[Oxidative stress and the brain].Nihon Ronen Igakkai Zasshi. 1997 Sep;34(9):706-10. Nihon Ronen Igakkai Zasshi. 1997. PMID: 9430979 Review. Japanese.
-
Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons.J Neural Transm (Vienna). 2005 Jan;112(1):111-9. doi: 10.1007/s00702-004-0121-3. Epub 2004 Mar 19. J Neural Transm (Vienna). 2005. PMID: 15599609 Review.
Cited by
-
Novel strategies in Parkinson's disease treatment: a review.Front Mol Neurosci. 2024 Aug 9;17:1431079. doi: 10.3389/fnmol.2024.1431079. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39183754 Free PMC article. Review.
-
Effective Doses of Low-Dose Naltrexone for Chronic Pain - An Observational Study.J Pain Res. 2024 Mar 21;17:1273-1284. doi: 10.2147/JPR.S451183. eCollection 2024. J Pain Res. 2024. PMID: 38532991 Free PMC article.
-
Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson's Disease?J Parkinsons Dis. 2024;14(2):227-244. doi: 10.3233/JPD-230315. J Parkinsons Dis. 2024. PMID: 38427502 Free PMC article. Review.
-
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets.Signal Transduct Target Ther. 2023 Sep 22;8(1):359. doi: 10.1038/s41392-023-01588-0. Signal Transduct Target Ther. 2023. PMID: 37735487 Free PMC article. Review.
-
Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases.Cells. 2023 Aug 11;12(16):2051. doi: 10.3390/cells12162051. Cells. 2023. PMID: 37626860 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources